Menu Back toSession 2: Patient-Focused Label for the Future: Hot Air or Real Opportunities?

Advancing Patient Science Workshop


Session 2: Patient-Focused Label for the Future: Hot Air or Real Opportunities?

Session Chair(s)

Aimad  Torqui

Aimad Torqui

  • Executive Director Global Regulatory Policy
  • MSD, Netherlands
Session 2: Patient-Focused Label for the Future: Hot Air or Real Opportunities?

Speaker(s)

D.K.Theo  Raynor, PhD, MPharm

Setting the Scene

D.K.Theo Raynor, PhD, MPharm

  • Professor of Pharmacy Practice
  • University of Leeds, United Kingdom
Elizabeth  Scanlan, PhD, MSc

ePI Principles

Elizabeth Scanlan, PhD, MSc

  • Scientific Communication Officer, Stakeholders and Communication Division
  • European Medicines Agency, Netherlands
Sabrina  Conti, LLM

Panel discussion with Q&A, with the additional participation of:

Sabrina Conti, LLM

  • Policy and Regulatory Coordinator
  • Medicines For Europe, Belgium
Deborah  Bebbington

Panel discussion with Q&A, with the additional participation of:

Deborah Bebbington

  • Vice President, Head of Global Labeling
  • Bayer Plc, United Kingdom
Cesar  Hernandez Garcia

Panel discussion with Q&A, with the additional participation of:

Cesar Hernandez Garcia

  • Head of Department, Department of Medicines for Human Use
  • Spanish Agency For Medicines and Medical Devices, Spain